Why the study?
Should statins for primary prevention of cardiovascular disease be targeted at high-risk individuals or the whole population?
Should statins for primary prevention of cardiovascular disease be targeted at high-risk individuals or the whole population?
Answers are grounded in this paper and cite their sources.
This editorial argues for a population-wide approach rather than a high-risk targeted approach for statin use in the primary prevention of cardiovascular disease.
US and UK groups revising recommendations on primary prevention of cardiovascular disease will have to decide whether to concentrate on high risk individuals or the whole population. Aroon Hingorani and Harry Hemingway argue that the evidence favours a population approach
No takes yet. Share an insight, caveat, or question.
Hingorani et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: